Free Trial

Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals logo
C$15.93 +0.29 (+1.85%)
As of 08/29/2025 04:00 PM Eastern

CPH vs. THCX, TLRY, CRON, GUD, ACB, WEED, FIRE, OGI, EPI, and ICC

Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include Hydropothecary (THCX), Tilray Brands (TLRY), Cronos Group (CRON), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), Organigram (OGI), ESSA Pharma (EPI), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Cipher Pharmaceuticals vs. Its Competitors

Cipher Pharmaceuticals (TSE:CPH) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

Cipher Pharmaceuticals has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$47.59M8.50C$11.41MC$0.4634.63
HydropothecaryN/AN/AN/AN/AN/A

In the previous week, Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
Cipher Pharmaceuticals Neutral
Hydropothecary Neutral

Cipher Pharmaceuticals currently has a consensus target price of C$14.75, indicating a potential downside of 7.41%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cipher Pharmaceuticals has a net margin of 59.92% compared to Hydropothecary's net margin of 0.00%. Cipher Pharmaceuticals' return on equity of 17.93% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals59.92% 17.93% 7.90%
Hydropothecary N/A N/A N/A

3.2% of Cipher Pharmaceuticals shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Cipher Pharmaceuticals beats Hydropothecary on 9 of the 9 factors compared between the two stocks.

Get Cipher Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPH vs. The Competition

MetricCipher PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$397.16MC$1.69BC$5.67BC$9.18B
Dividend YieldN/A2.91%3.99%6.53%
P/E Ratio34.63106.6283.1124.76
Price / Sales8.501,201.80517.459.33
Price / Cash3.5310.3737.7083.29
Price / Book4.0211.3910.575.35
Net IncomeC$11.41MC$20.70BC$3.27BC$301.20M
7 Day Performance5.50%0.94%0.57%2.94%
1 Month Performance30.68%4.85%5.99%6.14%
1 Year Performance-16.11%5.37%48.91%32.47%

Cipher Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CPH
Cipher Pharmaceuticals
0.3236 of 5 stars
C$15.93
+1.9%
C$14.75
-7.4%
-14.9%C$397.16MC$47.59M34.635
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
TLRY
Tilray Brands
N/AC$1.45
-7.6%
N/A-18.2%C$934.33MC$610.34M-3.502,650Gap Down
CRON
Cronos Group
N/AC$3.44
-2.0%
N/A+19.9%C$908.38MC$76.86M-19.14450News Coverage
GUD
Knight Therapeutics
0.6623 of 5 stars
C$6.39
+1.4%
C$7.15
+11.9%
+18.2%C$646.35MC$348.70M-21.33725High Trading Volume
ACB
Aurora Cannabis
0.1286 of 5 stars
C$6.58
-6.9%
C$8.75
+33.0%
-8.9%C$359.98MC$195.83M-8.131,073
WEED
Canopy Growth
0.3204 of 5 stars
C$1.73
-8.9%
C$1.55
-10.4%
-64.6%C$278.30MC$519.68M-0.252,700Positive News
Gap Down
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
OGI
Organigram
2.9047 of 5 stars
C$2.09
-1.4%
C$3.33
+59.1%
-5.2%C$258.20MC$180.58M-4.42987
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up

Related Companies and Tools


This page (TSE:CPH) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners